PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Essential oil from B. glabra leaves demonstrated anti-inflammatory and anti-nociceptive activities in rat models [PMID:30576771]
Methanol and dichloromethane extracts showed strong to moderate cytotoxicity against MCF-7, MDA-MB-231, CaSki, DU-145, and SW-480 cancer cell lines [PMID:30600762]
Biogenic silver nanoparticles synthesized from B. glabra flower extract exhibit antibacterial properties [PMID:36770576]
Evidence summary
PubMed sources
- 1.PMID: 37927559 (2023) — Bougainvillea glabra Choisy (Nyctinaginacea): review of phytochemistry and antimicrobial potential. · Frontiers in chemistry
- 2.PMID: 36770576 (2023) — Therapeutic Applications of Biogenic Silver Nanomaterial Synthesized from the Paper Flower of Bougainvillea glabra (Miami, Pink). · Nanomaterials (Basel, Switzerland)
- 3.PMID: 32956758 (2021) — Bougainvillea glabra (choisy): A comprehensive review on botany, traditional uses, phytochemistry, pharmacology and toxicity. · Journal of ethnopharmacology
- 4.PMID: 34064406 (2021) — Ribosome-Inactivating Proteins of Bougainvillea glabra Uncovered Polymorphism and Active Site Divergence. · Toxins
- 5.PMID: 16286311 (2006)